List Title | APhA DrugInfoLine

Nephrology

SORT BY: Most Recent Most Viewed

April 29, 2011

Heart failure common in patients receiving dialysis

READ

PREVIEW
A recent narrative review published in the American Journal of Kidney Disease highlighted the common occurrence of heart failure in patients on long-term dialysis, kidney disease–...
March 12, 2011

Less is more with ESAs for chronic kidney disease

READ

PREVIEW
According to analysis recently published in the American Journal of Kidney Diseases, erythropoiesis-stimulating agent (ESA) treatment in patients with hemoglobin levels greater than 12...
January 1, 2011

More frequent hemodialysis associated with decreased CV mortality

READ

PREVIEW
According to a landmark study recently published in the New England Journal of Medicine, increasing the frequency of in-center hemodialysis from three to six times per week may improve...
December 11, 2010

NAC: No short-term effects on serum creatinine or kidney function in patients with CKD

READ

PREVIEW
In a small, randomized, controlled trial, administration of four doses of oral N-acetylcysteine (NAC) had no significant effects on serum creatinine, cystatin C, urine protein, urine...
September 30, 2010

Renal drug dosing: Clarity and standardization needed

READ

PREVIEW
In a study evaluating renal drug dosing, researchers found that the prescribing information of many new drugs lacks clarity and standardization with regards to adjusting doses based on kidney...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.